Alliance Pharma Pty, Ltd. contains an expansive state-of-the-art lab, providing much-needed small and large molecule bioanalytical services for a region that currently has limited choices for bioanalytical support.
Alliance can also now transfer methods and maintain continuous project management across our 
global bioanalytical sites in the U.S. and Europe.
President Hao (Jason) Wang, Ph.D., leads an experienced team of scientists to provide broad range bioanalytical services. This new lab is outfitted with the latest LC-MS, ligand binding, flow cytometry, ELISpot and PCR instrumentation to support early and late phase research and will be capable of de novo method development, method transfers, method validation and sample analysis for pharmacokinetic (PK), biomarkers and immunogenicity.
